Annual Total Debt
$95.12 M
-$6.00 M-5.94%
31 December 2023
Summary:
Allogene Therapeutics annual total debt is currently $95.12 million, with the most recent change of -$6.00 million (-5.94%) on 31 December 2023. During the last 3 years, it has risen by +$44.31 million (+87.21%). ALLO annual total debt is now -5.94% below its all-time high of $101.12 million, reached on 31 December 2022.ALLO Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$85.14 M
-$1.85 M-2.13%
30 September 2024
Summary:
Allogene Therapeutics quarterly total debt is currently $85.14 million, with the most recent change of -$1.85 million (-2.13%) on 30 September 2024. Over the past year, it has dropped by -$4.97 million (-5.51%). ALLO quarterly total debt is now -48.49% below its all-time high of $165.28 million, reached on 30 September 2018.ALLO Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALLO Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.9% | -5.5% |
| 3 y3 years | +87.2% | +68.1% |
| 5 y5 years | +176.1% | +125.9% |
ALLO Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -5.9% | +87.2% | -15.8% | +68.1% |
| 5 y | 5 years | -5.9% | +176.1% | -15.8% | +125.9% |
| alltime | all time | -5.9% | -48.5% |
Allogene Therapeutics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $85.14 M(-2.1%) |
| June 2024 | - | $86.99 M(-2.2%) |
| Mar 2024 | - | $88.92 M(-6.5%) |
| Dec 2023 | $95.12 M(-5.9%) | $95.12 M(+5.6%) |
| Sept 2023 | - | $90.10 M(-1.9%) |
| June 2023 | - | $91.82 M(-7.9%) |
| Mar 2023 | - | $99.70 M(-1.4%) |
| Dec 2022 | $101.12 M(+38.3%) | $101.12 M(+4.6%) |
| Sept 2022 | - | $96.71 M(-1.6%) |
| June 2022 | - | $98.23 M(+42.3%) |
| Mar 2022 | - | $69.03 M(-5.6%) |
| Dec 2021 | $73.13 M | $73.13 M(+44.4%) |
| Sept 2021 | - | $50.64 M(-1.1%) |
| June 2021 | - | $51.21 M(-0.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $51.63 M(+1.6%) |
| Dec 2020 | $50.81 M(-4.2%) | $50.81 M(-0.1%) |
| Sept 2020 | - | $50.85 M(-0.4%) |
| June 2020 | - | $51.07 M(-0.9%) |
| Mar 2020 | - | $51.54 M(-2.8%) |
| Dec 2019 | $53.03 M(+53.9%) | $53.03 M(+40.7%) |
| Sept 2019 | - | $37.69 M(+8.1%) |
| June 2019 | - | $34.87 M(+0.2%) |
| Mar 2019 | - | $34.81 M(+1.0%) |
| Dec 2018 | $34.46 M(>+9900.0%) | $34.46 M(-79.2%) |
| Sept 2018 | - | $165.28 M(>+9900.0%) |
| June 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00 |
| Dec 2017 | $0.00 | - |
FAQ
- What is Allogene Therapeutics annual total debt?
- What is the all time high annual total debt for Allogene Therapeutics?
- What is Allogene Therapeutics annual total debt year-on-year change?
- What is Allogene Therapeutics quarterly total debt?
- What is the all time high quarterly total debt for Allogene Therapeutics?
- What is Allogene Therapeutics quarterly total debt year-on-year change?
What is Allogene Therapeutics annual total debt?
The current annual total debt of ALLO is $95.12 M
What is the all time high annual total debt for Allogene Therapeutics?
Allogene Therapeutics all-time high annual total debt is $101.12 M
What is Allogene Therapeutics annual total debt year-on-year change?
Over the past year, ALLO annual total debt has changed by -$6.00 M (-5.94%)
What is Allogene Therapeutics quarterly total debt?
The current quarterly total debt of ALLO is $85.14 M
What is the all time high quarterly total debt for Allogene Therapeutics?
Allogene Therapeutics all-time high quarterly total debt is $165.28 M
What is Allogene Therapeutics quarterly total debt year-on-year change?
Over the past year, ALLO quarterly total debt has changed by -$4.97 M (-5.51%)